ODN 21595 [1964506-28-2]

TargetMol Chemicals

ODN 21595 [1964506-28-2]

999

Chemical

Research Use Only

ODN 21595

ODN 21595, a guanine-modified inhibitor targeting TLR7 and TLR9, effectively inhibits the release of IFN-alpha and IL-6 without exhibiting cytotoxicity. It also reduces the expression of CD86 and HLA-DR, showcasing potential for systemic lupus erythematosus (SLE) research [1].

3 years

-20°C

12352200